Humacyte, Inc. (HUMA)
NASDAQ: HUMA · Real-Time Price · USD
0.6990
-0.0014 (-0.20%)
Jun 24, 2026, 4:00 PM EDT - Market closed
Humacyte Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 48.54 | 50.5 | 44.94 | 80.45 | 149.77 | 217.5 |
Short-Term Investments | - | - | - | - | 2.11 | 8 |
Cash & Short-Term Investments | 48.54 | 50.5 | 44.94 | 80.45 | 151.88 | 225.5 |
Cash Growth | -22.77% | 12.37% | -44.14% | -47.03% | -32.65% | 464.76% |
Accounts Receivable | 0.43 | 0.44 | - | - | 0.03 | 0.18 |
Inventory | 9.92 | 13.59 | - | - | - | - |
Other Current Assets | 4.91 | 3.48 | 53.13 | 3.04 | 2.3 | 3.66 |
Total Current Assets | 63.6 | 67.8 | 47.86 | 83.28 | 154.21 | 229.34 |
Net Property, Plant & Equipment | 46.08 | 47.69 | 38.55 | 44.1 | 49.41 | 57.19 |
Other Long-Term Assets | 0.88 | 0.88 | 51.46 | 0.84 | 0.68 | - |
Total Assets | 110.56 | 116.37 | 137.87 | 128.22 | 204.3 | 286.53 |
Accounts Payable | 5.08 | 5.4 | 4.49 | 6.49 | 1.6 | 2.09 |
Accrued Expenses | 8.68 | 10.54 | 11.42 | 9.34 | 7.11 | 6.76 |
Short-Term Debt | - | - | 0.89 | - | 8.57 | - |
Current Portion of Long-Term Debt | - | - | - | - | 8.57 | - |
Current Portion of Leases | 2.43 | 2.43 | 2.92 | 2.56 | 2.31 | 2.03 |
Other Current Liabilities | - | - | 1.12 | 0.05 | - | 0.17 |
Total Current Liabilities | 16.19 | 18.37 | 19.95 | 18.44 | 19.58 | 11.05 |
Long-Term Debt | 35.87 | 35.44 | 63.35 | 38.6 | 20.34 | 27.36 |
Long-Term Leases | 27.6 | 26.97 | 13.62 | 16.29 | 18.85 | 21.79 |
Other Long-Term Liabilities | 19.27 | 32.47 | 156.97 | 79.94 | 28.61 | 104.16 |
Total Long-Term Liabilities | 82.75 | 94.89 | 233.94 | 134.83 | 67.79 | 153.31 |
Total Liabilities | 98.93 | 113.26 | 190.54 | 114.68 | 87.37 | 164.36 |
Common Stock | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 |
Additional Paid-in Capital | 756.07 | 729.94 | 633.33 | 550.85 | 543.46 | 536.74 |
Retained Earnings | -744.47 | -726.85 | -686.02 | -537.31 | -426.54 | -414.57 |
Shareholders' Equity | 11.62 | 3.11 | -52.67 | 13.55 | 116.93 | 122.17 |
Total Liabilities & Equity | 110.56 | 116.37 | 137.87 | 128.22 | 204.3 | 286.53 |
Total Debt | 65.9 | 64.85 | 80.78 | 57.45 | 58.64 | 51.18 |
Net Cash (Debt) | -17.36 | -14.35 | -35.84 | 23 | 93.24 | 174.32 |
Net Cash Growth | - | - | - | -75.34% | -46.51% | 1923.02% |
Net Cash Per Share | -0.10 | -0.09 | -0.30 | 0.22 | 0.91 | 4.36 |
Book Value | 11.62 | 3.11 | -52.67 | 13.55 | 116.93 | 122.17 |
Book Value Per Share | 0.07 | 0.02 | -0.44 | 0.13 | 1.13 | 3.06 |
Tangible Book Value | 11.62 | 3.11 | -52.67 | 13.55 | 116.93 | 122.17 |
Tangible Book Value Per Share | 0.07 | 0.02 | -0.44 | 0.13 | 1.13 | 3.06 |